Metropolis Healthcare has executed Share Purchase and Shareholders' Agreement for the acquisition of 51% shareholding in Shraddha Diagnostic Centre (I). The purpose of the acquisition is to strengthen the presence of the company in the state of Gujarat, India.
Metropolis Healthcare offers a comprehensive range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.